Categories: Web and IT News

Stonegate Capital Partners Updates Coverage on Civeo Corporation (CVEO) 2025 Q1

Stonegate Capital Partners Updates Coverage on Civeo Corporation (CVEO) 2025 Q1


Dallas, Texas–(Newsfile Corp. – May 1, 2025) – Civeo Corporation (NYSE: CVEO): Stonegate Capital Partners updates their coverage on Civeo Corporation. Civeo reported negative free cash flow of ($13.5M) in 1Q25, down from $7.2M in the prior-year period, primarily due to negative operating cash flow of ($8.4M) and $5.3M in capital expenditures. Despite near-term headwinds, the Company reaffirmed its confidence in long-term free cash flow generation, supported by a capital-light model and a high mix of recurring asset-light services revenue. As part of its updated capital allocation strategy, Civeo increased its share repurchase authorization from 10% to 20% of shares outstanding and plans to use 100% of FCF to complete the program. In the quarter, the Company repurchased 153,000 shares for approximately $3.3M and suspended its quarterly dividend to prioritize buybacks and enhance financial flexibility. Net debt rose $20.9M quarter-over-quarter to $59.0M, resulting in a net leverage ratio of 0.8x.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • Reported revenues of $144.0M, net loss of $9.8M and Adjusted EBITDA of $12.7M.
  • CVEO announced a share repurchase authorization from 10% to 20% of shares outstanding, suspending its quarterly cash dividend.
  • CVEO revised its 2025 guidance, with revenue between $620M and $650M and Adj. EBITDA of $75M to $85M.

Click image above to view full announcement.


About Stonegate

Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/250449

 

View more news from Reportable, Inc.

You are receiving this email because you have previously indicated your interest in receiving news for Reportable, Inc.

If you no longer want to receive messages from us, you can click here to unsubscribe.

Anti-Spam Policy | Privacy Policy

 

The post Stonegate Capital Partners Updates Coverage on Civeo Corporation (CVEO) 2025 Q1 first appeared on PressReleaseCC.

Stonegate Capital Partners Updates Coverage on Civeo Corporation (CVEO) 2025 Q1 first appeared on Web and IT News.

awnewsor

Recent Posts

Freelancers, Avoid Tax Season Headaches with These Simple Steps by PayStubCreator

NEW YORK – Freelancers often face unique challenges during tax season. Unlike traditional employees who…

2 hours ago

Oligonucleotide CDMO Market to Hit $6.73 Billion by 2029 Amid Surge in Outsourced Gene-Based Drug Manufacturing

Oligonucleotide CDMO Market by Service (Contract Manufacturing (Clinical, Commercial), Development), Type (ASO, SiRNA, (CPG Oligos,…

2 hours ago

Retail Analytics Market Strategic Insights, Technological Advancements, Growth Drivers, Opportunities and Leading Key Vendors To 2031

Microsoft (US), IBM (US), SAP (Germany), Oracle (US), Salesforce (US), MicroStrategy (US), SAS Institute (US),…

2 hours ago

Digital Identity Solutions Market Latest Trends, Opportunities, Trends, Demand, Analysis and Future Outlook (2025-2031)

Digital Identity Solutions Market by Hardware (RFID Reader & Encoder, Hardware-Based Tokens, Processor ID Cards),…

2 hours ago

Latest Research on Battery Type in the Battery Energy Storage System (BESS) Market by MarketsandMarkets™

Battery Energy Storage System (BESS) Market The Battery Energy Storage System (BESS) Market is projected…

2 hours ago

Oligonucleotide Synthesis Market Projected to Reach $24.7 Billion by 2030 Driven by Expanding Genomics Applications

Oligonucleotide Synthesis Market by Product ((Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom,…

2 hours ago

This website uses cookies.